Trial Profile
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK-0954/Losartan Potassium in Pediatric Patients With Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Organon
- 03 May 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 15 Mar 2013 New source identified and integrated (Clinical Trials Registry - India; CTRI2009-091-000045).
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.